What you need to know about DAPT in high-bleeding risk patients

Sponsored by Terumo

M. Alasnag, T. Cuisset, P. Smits, M. Valgimigli

Summary

This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.

Learning Objectives

To learn about drivers for DAPT duration
To learn how to assess HBR
To address open questions about DAPT for HBR patients through complex cases discussion